Painful Traumatic Trigeminal Neuropathy: An Open Study on the Pharmacotherapeutic Response to Stepped Treatment

Aims: To evaluate pharmacotherapeutic success in patients with painful traumatic trigeminal neuropathy (PTTN) and to identify patient or pain characteristics that may predict treatment outcome. Methods: Pharmacotherapy was instituted for PTTN patients and was based on widely accepted protocols for neuropathic pain and conducted in an open fashion. Outcome was assessed by employing prospective diaries recording pain intensity measured with an 11-point (0 to 10) verbal pain score (VPS). Individual characteristics in the patients and their influence on outcome were analyzed. Treatment results in the PTTN patients were compared with those in classical trigeminal neuralgia (CTN) patients, who were used as a comparative cohort. Data were analyzed with a Pearson chi-square test for nominal variables and with an independent samples t test or analysis of variance for continuous variables. Results: A total of 145 patients were included: 91 with PTTN and 54 with CTN. In PTTN patients, 11% had a ≥ 50% reduction in pain intensity. Higher VPS scores in the PTTN patients were associated with a significantly reduced response to therapy (P = .03). No other pain-related or demographic parameters were associated with treatment outcome in the PTTN patients. Also the response rate of PTTN patients was significantly inferior to that of CTN patients, 74.1% of whom attained a significant reduction in pain intensity (P < .001). Conclusion: This study underpins the poor pharmacotherapeutic prognosis of PTTN. The results support findings on neuropathic pain in other sites and point to the need for further research and reexamination of current PTTN treatment protocols.

antidepressants; antiepileptic drugs; orofacial pain; trigeminal neuralgia

1. Haanpaa M, Attal N, Backonja M, Baron R, et al. NeuPSIG guidelines on neuropathic pain assessment. Pain 2011;152:14–27.

2. Tal M, Devor M. Anatomy and neurophysiology of orofacial pain. In: Sharav Y, Benoliel R (eds). Orofacial Pain and Headache. Edinburgh: Mosby Elsevier, 2008:19–44.

3. Graff-Radford SB, Solberg WK. Atypical odontalgia. J Craniomandib Disord 1992;6:260–265.

4. Marbach JJ. Phantom tooth pain: Deafferentation pain. Pa Dent J (Harrisb) 1984;51:32–33.

5. Marbach JJ, Hulbrock J, Hohn C, Segal AG. Incidence of phantom tooth pain: An atypical facial neuralgia. Oral Surg Oral Med Oral Pathol 1982;53:190–193.

6. Marbach JJ, Raphael KG. Phantom tooth pain: A new look at an old dilemma. Pain Med 2000;1:68–77.

7. Zagury JG, Eliav E, Heir GM, et al. Prolonged gingival cold allodynia: A novel finding in patients with atypical odontalgia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;111: 312–319.

8. de Leeuw R (ed). Orofacial Pain: Guidelines for Assessment, Classification, and Management. American Academy of Orofacial Pain. Chicago: Quintessence, 2008.

9. Pfaffenrath V, Rath M, Pollmann W, Keeser W. Atypical fa-cial pain--application of the IHS criteria in a clinical sample. Cephalalgia 1993;13(suppl 12):84–88.

10. Agostoni E, Frigerio R, Santoro P. Atypical facial pain: Clinical considerations and differential diagnosis. Neurol Sci 2005;26(Suppl 2):s71–s74.

11. Olesen J, Bousser M-G, Diener HC, Dodick D, First M, Goadsby PJ, et al. The International Classification of Headache Disorders, 2nd Edition. 2004;24(suppl 1):24-150.

12. Woda A, Pionchon P. A unified concept of idiopathic orofacial pain: Clinical features. J Orofac Pain 1999;13:172–184; discussion 185–195.

13. Jaaskelainen SK, Forssell H, Tenovuo O. Electrophysiological testing of the trigeminofacial system: Aid in the diagnosis of atypical facial pain. Pain 1999;80:191–200.

14. Benoliel R, Zadik Y, Eliav E, Sharav Y. Peripheral painful traumatic trigeminal neuropathy: Clinical features in 91 cases and proposal of novel diagnostic criteria. J Orofac Pain 2012;26:49–58.

15. Devor M, Amir R, Rappaport ZH. Pathophysiology of trigeminal neuralgia: The ignition hypothesis. Clin J Pain 2002;18:4–13.

16. Kuncz A, Voros E, Barzo P, et al. Comparison of clinical symptoms and magnetic resonance angiographic (MRA) results in patients with trigeminal neuralgia and persistent idiopathic facial pain. Medium-term outcome after microvascular decompres-sion of cases with positive MRA findings. Cephalalgia 2006; 26:266–276.

17. Obermann M, Yoon MS, Ese D, et al. Impaired trigeminal nociceptive processing in patients with trigeminal neuralgia. Neurology 2007;69:835–841.

18. Benoliel R, Eliav E, Sharav Y. Self-reports of pain-related awakenings in persistent orofacial pain patients. J Orofac Pain 2009;23:330–338.

19. Benoliel R, Birman N, Eliav E, Sharav Y. The International Classification of Headache Disorders: Åccurate diagnosis of orofacial pain? Cephalalgia 2008;28:752–762.

20. Benoliel R, Eliav E, Sharav Y. Classification of chronic orofacial pain: Åpplicability of chronic headache criteria. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;110:729–737.

21. Benoliel R, Eliav E, Sharav Y. Self-reports of pain-related awakenings in persistent orofacial pain patients. J Orofac Pain 2009;23:330–338.

22. Benoliel R, Sharav Y. Tender muscles and masticatory myofascial pain diagnosis: How many or how much? J Orofac Pain 2009;23:300–301.

23. Benoliel R, Kahn J, Eliav E. Peripheral painful traumatic trigeminal neuropathies. Oral Dis 2012;18:317–332.

24. Dworkin RH, O’Connor AB, Backonja M, et al. Pharmacologic management of neuropathic pain: Evidence-based recommendations. Pain 2007;132:237–251.

25. Finnerup NB, Otto M, Jensen TS, Sindrup SH. An evidence-based algorithm for the treatment of neuropathic pain. MedGenMed 2007;9:36.

26. Dworkin RH, O’Connor AB, Audette J, et al. Recommendations for the pharmacological management of neuropathic pain: An overview and literature update. Mayo Clin Proc 2010;85: S3–S14.

27. Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010;17:e1113–e1188.

28. Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measuredon an 11-point numerical pain rating scale. Pain 2001; 94:149–158.

29. Sindrup SH, Jensen TS. Antidepressants in the treatment of neuropathic pain. In: Hanson PT, Fields HL, Hill RG, MarchettiniP (eds). Neuropathic Pain: Pathophysiology and Treatment. Seattle: IASP Press, 2001:169–183.

30. McQuay HJ, Tramer M, Nye BA, Carroll D, Wiffen PJ, Moore RA. A systematic review of antidepressants in neuropathic pain. Pain 1996;68:217–227.

31. Sindrup SH, Jensen TS. Pharmacotherapy of trigeminal neuralgia. Clin J Pain 2002;18:22–27.

32. Wiffen P, Collins S, McQuay H, Carroll D, Jadad A, Moore A. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev 2005:CD001133.

33. Benoliel R, Birenboim R, Regev E, Eliav E. Neurosensory changes in the infraorbital nerve following zygomatic fractures. 2005;99:657–665.

34. Jaaskelainen SK, Teerijoki-Oksa T, Virtanen A, Tenovuo O, Forssell H. Sensory regeneration following intraoperatively verified trigeminal nerve injury.Neurol 2004;62:1951–1957.

35. Benoliel R, Eliav E, Elishoov H, Sharav Y. Diagnosis and treatment of persistent pain after trauma to the head and neck. J Oral Maxillofac Surg 1994;52:1138–1147; discussion 1147–1148.

36. Devor M, Govrin-Lippmann R, Rappaport ZH. Mechanism of trigeminal neuralgia: An ultrastructural analysis of trigeminal root specimens obtained during microvascular decompression surgery. J Neurosurg 2002;96:532–543.

37. Rappaport ZH, Govrin-Lippmann R, Devor M. An electronmicroscopic analysis of biopsy samples of the trigeminal root taken during microvascular decompressive surgery. Stereotact Funct Neurosurg 1997;68:182–186.

38. Jaaskelainen S. Traumatic nerve injury: Diagnosis, recovery, and risk factors for neuropathic pain. In: Castro-Lopes J (ed). Current Topics in Pain: 12th World Congress on Pain. Seattle: IASP Press, 2009:1–20.

39. Finnerup NB, Sindrup SH, Jensen TS. The evidence for pharmacological treatment of neuropathic pain. Pain 2010;150: 573–581.

40. van Seventer R, Bach FW, Toth CC, et al. Pregabalin in the treatment of post-traumatic peripheral neuropathic pain: A randomized double-blind trial. Eur J Neurol 2010;17:1082–1089.

41. Jenkins TM, Smart TS, Hackman F, Cooke C, Tan KK. Efficient assessment of efficacy in post-traumatic peripheral neuro-pathic pain patients: Pregabalin in a randomized, placebo-controlled, crossover study. J Pain Res 2012;5:243–250.

42. Zakrzewska JM, Patsalos PN. Long-term cohort study comparing medical (oxcarbazepine) and surgical management of intractable trigeminal neuralgia. Pain 2002;95:259–266.

43. Sato J, Saitoh T, Notani K, Fukuda H, Kaneyama K, Segami N. Diagnostic significance of carbamazepine and trigger zones in trigeminal neuralgia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;97:18–22.

44. Eisenberg E, McNicol ED, Carr DB. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of non-malignant origin: Systematic review and meta-analysis of randomized controlled trials. JAMA 2005;293:3043–3052.

45. Rowbotham MC, Goli V, Kunz NR, Lei D. Venlafaxine extended release in the treatment of painful diabetic neuropathy: A double-blind, placebo-controlled study. 2004;110:697–706.

46. Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005;352:1324–1334.

47. Simpson DA. Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. 2001;3:53–62.

48. Chaparro LE, Wiffen PJ, Moore RA, Gilron I. Combination pharmacotherapy for the treatment of neuropathic pain in adult. Cochrane Database Syst Rev 2012;7:CD008943.

49. Baastrup C, Finnerup NB. Pharmacological management of neuropathic pain following spinal cord injury. CNS Drugs 2008;22:455–475.

50. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992;326:1250–1256.

51. Sindrup SH, Bach FW, Madsen C, Gram LF, Jensen TS. Venlafaxine versus imipramine in painful polyneuropathy: A randomized, controlled trial. Neurology 2003;60:1284–1289.

52. Berilgen MS, Bulut S, Gonen M, Tekatas A, Dag E, Mungen B. Comparison of the effects of amitriptyline and flunarizine on weight gain and serum leptin, C peptide and insulin levels when used as migraine preventive treatment. Cephalalgia 2005;25:1048–1053.

53. Fromm GH. Baclofen as an adjuvant analgesic. J Pain Symptom Manage 1994;9:500–509.

54. Sehgal N, Manchikanti L, Smith HS. Prescription opioid abuse in chronic pain: A review of opioid abuse predictors and strategies to curb opioid abuse. Pain Physician 2012;15 (3 suppl):ES67–ES92.

55. Benoliel R, Eliav E, Tal M. No sympathetic nerve sprouting in rat trigeminal ganglion following painful and non-painful infraorbital nerve neuropathy. Neurosci Lett 2001;297:151–154.

56. Fried K, Bongenhielm U, Boissonade FM, Robinson PP. Nerve injury-induced pain in the trigeminal system. Neuroscientist 2001;7:155–165.

57. Tauben D. Chronic pain management: Measurement-based step care solutions. Pain Clinical Updates. Seattle: IASP, 2012.